2-bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione
- $29.8 - $424
- Product name: 2-bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione
- CAS: 730-73-4
- MF: C15H8BrClO2
- MW: 335.58
- EINECS:
- MDL Number:MFCD00183009
- Synonyms:2-bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione;2-Bromo-2-(4-chloro-phenyl)-indan-1,3-dione;1H-Indene-1,3(2H)-dione, 2-bromo-2-(4-chlorophenyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Sigma-Aldrich
Package
- 50MG
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product number7447BA
- Product description2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione
- Packaging1g
- Price$212
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12038929
- Product description2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione 95+%
- Packaging5g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12038929
- Product description2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione 95+%
- Packaging10g
- Price$424
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS43320
- Product description2-BROMO-2-(4-CHLORO-PHENYL)-INDAN-1,3-DIONE AldrichCPR
- Packaging50MG
- Price$29.8
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7447BA | 2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione | 1g | $212 | 2021-12-16 | Buy |
Crysdot | CD12038929 | 2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione 95+% | 5g | $306 | 2021-12-16 | Buy |
Crysdot | CD12038929 | 2-Bromo-2-(4-chlorophenyl)-1H-indene-1,3(2H)-dione 95+% | 10g | $424 | 2021-12-16 | Buy |
Sigma-Aldrich | S43320 | 2-BROMO-2-(4-CHLORO-PHENYL)-INDAN-1,3-DIONE AldrichCPR | 50MG | $29.8 | 2024-03-01 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|